Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Discover tailored wealth management advice for women to maximize their assets. Enhance your financial strategy now.
18,329 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
A durable capex cycle is forming around upgrading the power grid to handle AI, EV charging, and reshoring needs. Anal...
AppLovin is set to report Q1 2026 after the close, with traders eyeing revenue momentum, margins and AI advertising s...
Horizon (HRZN) investors want clarity on Q3 2025 results and what comes next. This article breaks down horizon (hrzn)...
Disney beats Q2 expectations, sending Wall Street into a target-upgrade cycle. JPMorgan, Barclays and Guggenheim lift...
Caris Life Sciences blends lab testing with AI-driven insights to tackle oncology challenges. This piece breaks down ...
Remax Holdings posted a revenue decline and a sharper net loss in Q1 2026, while debt rose to $436 million. Real Brok...
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Rising rates don’t have to stop your rental plans. This guide breaks down actionable strategies to land cash-flowing ...
A lesser-known cloud platform is delivering eye-popping gains as AI demand climbs. Discover why this stock crushing N...
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...
EUFN’s payouts face structural risk amid regulator changes and currency swings, threatening steady income for U.S.-ba...